CONGENITAL HYPERINSULINISM
Clinical trials for CONGENITAL HYPERINSULINISM explained in plain language.
Never miss a new study
Get alerted when new CONGENITAL HYPERINSULINISM trials appear
Sign up with your email to follow new studies for CONGENITAL HYPERINSULINISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New weekly shot shows promise for rare low blood sugar disorder
Disease control OngoingThis study tests a new medicine called HM15136 for people aged 2 and older with congenital hyperinsulinism (CHI) who still have low blood sugar despite standard treatments. The medicine is given as a weekly shot for 8 weeks. The goal is to see if it is safe and helps control bloo…
Matched conditions: CONGENITAL HYPERINSULINISM
Phase: PHASE2 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug aims to control blood sugar in kids with rare condition
Disease control OngoingThis study is testing the long-term safety of dasiglucagon, a drug given as a continuous injection under the skin, in children with congenital hyperinsulinism (a condition causing dangerously low blood sugar). The trial includes 42 children who completed earlier studies. Research…
Matched conditions: CONGENITAL HYPERINSULINISM
Phase: PHASE3 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Promising new treatment for rare sugar disorder moves to final testing phase
Disease control OngoingThis study tests an investigational drug called RZ358 for people with congenital hyperinsulinism, a rare condition causing dangerously low blood sugar. The trial involves 56 participants aged 3 months to 45 years who still have low blood sugar despite standard treatments. Over 24…
Matched conditions: CONGENITAL HYPERINSULINISM
Phase: PHASE3 • Sponsor: Rezolute • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC